
News|Articles|May 23, 2024
Don’t underestimate the "small stuff"
Author(s)Eurofins BioPharma Product Testing
Learn about the importance of considering human factors testing beyond the initial validation phase. Through two case studies, it illustrates how seemingly minor product changes can trigger regulatory scrutiny. The message is clear: proactive testing and expert guidance are essential to navigate regulatory requirements effectively.
Trending on Pharmaceutical Technology
1
CPHI Milan Names 2026 Pharma Awards Finalists
2
Lilly's $2.875B Merida Deal Has Implications for Autoantibody Diseases
3
From Phase 1 Screening to Commercial Strategy: Selecting the Right Amorphous Solid Dispersion Technology Early
4
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
5
